Close Menu

Trovagene

NEW YORK (GenomeWeb News) – PerkinElmer this week said that its board of directors has declared a quarterly dividend of $.07 per share payable on Aug. 10, to all shareholders of record at the close of business on July 20.

NEW YORK (GenomeWeb News) – Trovagene today announced that underwriters of its public offering have exercised the over-allotment option to purchase 172,500 additional units to raise a total of nearly $10.6 million in gross proceeds.

Trovagene said this week that it has entered into a memorandum of understanding with Strand Life Sciences to offer Trovagene's urine-based human papillomavirus screening test in India and South Asia.

NEW YORK (GenomeWeb News) – Trovagene today said that it has entered into a memorandum of understanding with Strand Life Sciences, under which Strand will license and validate Trovagene's human papillomavirus urine test and high-risk HPV DNA assay.

This article has been updated from a previous version to correct the list price of the QX100 system.

NEW YORK (GenomeWeb News) – Trovagene announced late on Tuesday the pricing of a public offering of 1.15 million units and said that its shares will begin trading on the Nasdaq Capital Market today under ticker symbol "TROV".

This article has been updated from a previous version to include information about the current status of Fluidigm's collaboration with Novartis.

Trovagene said this week that Carlo Croce has joined its scientific advisory board.

Originally published May 2. Updated May 3 to include additional details of Trovagene's product commercialization plans.

Molecular diagnostic company Trovagene has appointed Charlie Rodi to vice president and chief technology officer.

Pages

A new paper says an effort to introduce gene drives into mosquitos altered the genetic makeup of the local mosquitos, but the company behind the project says the paper is flawed.

Virginia's Department of Forensic Science is offering attorneys a course on DNA testing, the Virginian-Pilot reports.

Researchers examine changes in the genomes of emmer wheat populations where the climate has warmed, the BBC reports.

In Cell this week: microinjection of CRISPR-Cas9 enables targeted mutations in Anolis, melanoma proteomic profiling, and more.